Unusual Biotech Movers (DSCO, GNTA, IDMI, DDSS, POTP, DARA)
Discovery Laboratories Inc. (NASDAQ: DSCO) shares are up after a report that their drug Surfaxin, a respiratory distress syndrome treatment for premature infants, should gain FDA approval by May. In ...Read Full Story »
